Felix J Woitek
Overview
Explore the profile of Felix J Woitek including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
219
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mangner N, Schrader M, Haussig S, Kiefer P, Leontyev S, Kappert U, et al.
J Clin Med
. 2025 Jan;
14(1.
PMID: 39797218
Patients with end-stage kidney disease (ESRD) represent a high-risk population in terms of both development of and death by cardiovascular diseases. Outcome data of ESRD patients with severe aortic valve...
2.
Scheller B, Mangner N, Jeger R, Afan S, Mahfoud F, Woitek F, et al.
EuroIntervention
. 2024 Nov;
20(21):e1322-e1329.
PMID: 39492703
Background: Paclitaxel-coated balloons (PCB) are a viable alternative to drug-eluting stents in the treatment of de novo coronary lesions. Whether sirolimus represents an alternative to paclitaxel for drug-coated balloons remains...
3.
Mierke J, Nowack T, Poege F, Schuster M, Sveric K, Jellinghaus S, et al.
Heart Lung Circ
. 2024 Oct;
33(12):1670-1679.
PMID: 39368945
Background: The use of microaxial percutaneous left ventricular assist devices (pLVADs) in cardiogenic shock (CS) has increased in recent years, despite limited evidence, and data on sex disparities are particularly...
4.
Moller J, Engstrom T, Jensen L, Eiskjaer H, Mangner N, Polzin A, et al.
N Engl J Med
. 2024 Apr;
390(15):1382-1393.
PMID: 38587239
Background: The effects of temporary mechanical circulatory support with a microaxial flow pump on mortality among patients with ST-segment elevation myocardial infarction (STEMI) complicated by cardiogenic shock remains unclear. Methods:...
5.
Steul J, Abdel-Wahab M, Stankowski T, Haussig S, Woitek F, Gasior T, et al.
Clin Res Cardiol
. 2023 Dec;
PMID: 38078955
Background: Valve-in-valve (ViV) transcatheter aortic valve implantation (TAVI) is a viable alternative to redo surgery in selected patients with bioprosthetic valve dysfunction. Most ViV-TAVI procedures have been performed in stented...
6.
Gasior T, Woitek F, Schroth A, Abdel-Wahab M, Crusius L, Haussig S, et al.
J Clin Med
. 2023 Mar;
12(5).
PMID: 36902604
Background: The two most common organisms found in infective endocarditis following transcatheter aortic valve implantation (TAVI-IE) are (EC-IE) and (SC-IE). We aimed to compare clinical characteristics and outcomes of patients...
7.
Masdjedi K, Tanaka N, Van Belle E, Porouchani S, Linke A, Woitek F, et al.
EuroIntervention
. 2021 Oct;
17(18):1498-1505.
PMID: 34647890
Background: Fractional flow reserve (FFR)-guided percutaneous coronary intervention (PCI) is superior to angiography-guided PCI. The clinical uptake of FFR has been limited, however, by the need to advance a wire...
8.
Woitek F, Haussig S, Mierke J, Linke A, Mangner N
Clin Res Cardiol
. 2021 Jun;
110(9):1525-1530.
PMID: 34156523
Remote proctoring by advanced digital technologies may help to overcome pandemic, geographic, and resource-related constraints for mentoring and educating interventional cardiology skills. We present a case series of patients undergoing...
9.
Stachel G, Woitek F, Crusius L, Haussig S, Kiefer P, Leontyev S, et al.
Can J Cardiol
. 2020 May;
37(3):450-457.
PMID: 32450289
Background: Data about the impact of left-atrial appendage thrombosis (LAAT) on early safety and mortality in patients undergoing transfemoral transcatheter aortic valve implantation (TF-TAVI) are scarce. We aimed to investigate...
10.
Woitek F, Stachel G, Kiefer P, Haussig S, Leontyev S, Schlotter F, et al.
Int J Cardiol
. 2019 Nov;
300:80-86.
PMID: 31740140
Background: The use of bioprostheses for surgical aortic valve replacement increased substantially within the last years. In case of prosthesis failure, re-SAVR is standard of care, whereas valve-in-valve deployment of...